Pfizer to acquire Seagen for USD 43 billion Ruchika Sharma14 March 2023 12:00 PM ISTThe proposed acquisition is also expected to enable for combination potential across both the Seagen and Pfizer pipelines and will leverage Pfizer's...
CDSCO Panel Rejects Pfizer's Proposal to Waive Phase IV CT of Antimicrobial FDC Dr. Divya Colin13 March 2023 6:00 PM ISTNew Delhi: Highlighting that there is no unmet need for a Phase IV clinical trial study waiver, the Subject Expert Committee (SEC) functional under...
GSK, Pfizer ready to launch RSV vaccines for older adults in US Ruchika Sharma12 March 2023 2:30 PM ISTRSV is a leading cause of pneumonia in infants and the elderly, and decades of research have finally resulted in the two successful vaccines Pfizer...
Pfizer bags USFDA nod for migraine nasal spray ZAVZPRET Ruchika Sharma11 March 2023 11:15 AM ISTZAVZPRET is anticipated to be available in pharmacies in July 2023.
Alembic Pharma Hypertension drug Prazosin Hydrochloride gets USFDA okay Ruchika Sharma9 March 2023 5:15 PM ISTVadodara: Drugmaker Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug...
Pfizer, BioNTech submit application to USFDA for emergency use nod of Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma2 March 2023 4:15 PM ISTNew York: Pfizer Inc. and BioNTech SE have submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use...
Merck scraps another prostate cancer study as Keytruda therapy disappoints Ruchika Sharma1 March 2023 2:15 PM ISTNew Delhi: Merck & Co said on Tuesday it will stop a late-stage trial evaluating a combination therapy with its cancer drug Keytruda after interim...
Submit Phase II CT safety data: CDSCO panel tells Pfizer over Ritlecitinib Dr. Divya Colin27 Feb 2023 6:00 PM ISTNew Delhi: Denying the proposal presented by the pharma major Pfizer for Phase III CT of the drug Ritlecitinib, the Subject Expert Committee (SEC)...
Pfizer RSV vaccine for elderly linked to Guillain-Barre risk, says USFDA MD Bureau27 Feb 2023 4:30 PM ISTPfizer stated that its shot is a "well-tolerated and safe vaccine, with a benefit-to-risk ratio that is favourable".
Pfizer in talks to acquire Seagen for likely for more than USD 30 bilion - WSJ Ruchika Sharma27 Feb 2023 3:30 PM ISTUS: Pfizer Inc is in early talks to acquire drugmaker Seagen Inc, the Wall Street Journal reported late on Sunday, citing people familiar with the...
Pfizer, BioNTech seek USFDA nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine for ages 12 years and older as primary series or booster Ruchika Sharma25 Feb 2023 12:30 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that they have submitted a supplemental Biologics License Application (sBLA) to the U.S....
USFDA grants priority review to Pfizer Elranatamab for relapsed or refractory multiple myeloma Ruchika Sharma24 Feb 2023 2:30 PM ISTElranatamab is an investigational, off-the-shelf, humanized BCMA CD3-targeted BsAb.
